炎症性肠病
医学
恶性肿瘤
结肠炎
结直肠癌
免疫系统
疾病
癌症
免疫检查点
免疫学
免疫疗法
内科学
作者
Marco Vincenzo Lenti,Giovanni Santacroce,Antonio Di Sabatino
摘要
Lay Summary Managing inflammatory bowel disease in cancer patients is challenging due to concerns about biologics’ effects on malignancy. Recent evidence suggests a low risk of cancer progression, but data gaps persist. Research on immune checkpoint inhibitor-induced colitis and biologic safety remains limited.
科研通智能强力驱动
Strongly Powered by AbleSci AI